Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02807623 · ClinicalTrials.gov registry record · NA
Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation
A NA study of Immune System and Related Disorders, sponsored by Womack Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT02807623 is a NA study of Immune System and Related Disorders that has completed, run by Womack Army Medical Center. The registered enrollment target is 300 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT02807623, a NA study of Immune System and Related Disorders, has completed, sponsored by Womack Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this clinical investigation is to evaluate the efficacy and immunologic effects of a non-pharmacological exercise intervention (push-ups) compared to an oral NSAID (ibuprofen) and an oral placebo to decrease local injection site inflammation symptoms of delayed pain, erythema, and edema and any impact on serologic antibody immune response after influenza vaccine receipt.
Conditions Studied
Interventions
- DRUG Ibuprofen
- DRUG oral placebo
- BEHAVIORAL Compound Exercise of Push-ups
Study Locations (2)
Maryland
- Walter Reed National Military Medical Center - Bethesda
North Carolina
- Womack Army Medical Center - Fort Bragg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02807623
The ClinicalTrials.gov registry entry for NCT02807623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Womack Army Medical Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Immune System and Related Disorders appearing as the primary indexed condition, and to 3 interventions - of which Ibuprofen is the first listed.
NCT02807623 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02807623 about?
NCT02807623 is a clinical study titled "Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation". The purpose of this clinical investigation is to evaluate the efficacy and immunologic effects of a non-pharmacological exercise intervention (push-ups) compared to an oral NSAID (ibuprofen) and an oral placebo to decrease local injection site inflammation symptoms of delayed pain, erythema, and ede...
What is the current status of trial NCT02807623?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2016-09. Estimated completion is 2018-12.
What conditions does trial NCT02807623 study?
This clinical trial studies the following conditions: Immune System and Related Disorders.
What interventions are being tested in trial NCT02807623?
The interventions under investigation include: Ibuprofen (DRUG), oral placebo (DRUG), Compound Exercise of Push-ups (BEHAVIORAL).
Who is sponsoring clinical trial NCT02807623?
This trial is sponsored by Womack Army Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02807623 being conducted?
This trial has 2 study locations across Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Immune System and Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.